Pharmaceutical composition

A topical pharmaceutical composition with magnesium salts and lipoic acid/MSM effectively treats and prevents viral infections and skin diseases, addressing the limitations of current treatments by providing symptom relief and prevention without significant side effects.

JP2026519984APending Publication Date: 2026-06-19AEROTECH AUSTRALIA
0 Cites 0 Cited by

Patent Information

Application Number
JP2025565544
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-23
Filing Date
2024-05-22
Publication Date
2026-06-19

AI Technical Summary

Technical Problem

Current treatments for viral infections and skin diseases such as herpes zoster, varicella-zoster infection, herpes simplex, hidradenitis suppurativa, psoriasis, acne, atopic dermatitis, atopic eczema, postherpetic neuralgia, and SARS-CoV-2 are either ineffective or have significant side effects, and there is a need for more curative options.

Method used

A pharmaceutical composition comprising magnesium salts, lipoic acid, and methylsulfonylmethane (MSM), optionally with sodium bicarbonate and lemon extract, formulated for topical application, which is applied as a cream, spray, or liquid.

Benefits of technology

The composition effectively treats and prevents these conditions by reducing symptoms like cracked skin, skin bleeding, skin peeling, and pain, offering a curative and side-effect-reduced alternative to existing treatments.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

Pharmaceutical compositions of alpha-lipoic acid and / or methylsulfonylmethane (MSM) and magnesium salts, useful for the treatment, prevention, or reduction of the severity of viral infections and / or skin diseases, are provided herein. Methods for preparing the pharmaceutical compositions and methods for using the pharmaceutical compositions in therapeutic treatments are also provided.
Need to check novelty before this filing date? Find Prior Art